Introduction
Malaria, one of the three most important diseases in Africa according to the World Health Organization (WHO), is a major cause of morbidity and mortality worldwide, especially in developing countries where it has serious economic and social costs [1] . Currently, multi-drug resistance has become one of the most important problems impeding malaria control efforts [2, 3] . This has led to attempts to discover other antimalarial agents, mainly from plant sources. For decades, Plants from different botanical sources have been used by various traditional medical practitioners (TMPs) for the treatment and cure of malaria [4, 5] . For example quinine and artemisinin have been derived from traditional medicine and plant extracts [6] .
About 80% of the populations of many developing countries still use traditional medicines for their health care. Over 90% of Nigerians in rural areas and about 40% of the population living in urban areas depend partly or wholly on traditional medicines [7] . Due to economic reasons, most of the people in developing countries are precluded from the luxury of access to modern therapy. This has made the people to rely on plant and animal resources for their health care over centuries [6] .
Several studies have been undertaken to evaluate not only the inhibitory effects of various plant extracts on P. falciparum using in vitro culture, but also in vivo anti-malarial properties on Plasmodium berghei-infected mice [8, 9] .
Parkia biglobosa (Jacq.) R. Br. Ex G. Don popularly known as African locust bean tree is a perennial, deciduous tree common in West African region. Medicines derived from African locust bean tree are of great value to rural communities that cannot afford or do not have access to "modern medicine". In Nigeria, many traditional medicine practitioners have identified the stem bark and leaf of African locust bean tree as a condiment of great value in the treatment of malaria [10] . The stem bark is boiled and taken orally in form of decoction for malaria fever; there are also reports on the use of the bark of Parkia biglobosa , for the treatment of fever in Ghana [4] .
The aim of this study is to evaluate the antiplasmodial activity of the phenolic compounds isolated from the stem bark of Parkia biglobosa.
II. Materials And Methods
The stem barks of Parkia biglobosa tree were collected in the month of February, 2009 in Chaza village in Niger state of Nigeria. The identification and authentification were done by (Ethno botanist) Mallam Muazam Wudil of department of Medicinal Plant Research and Traditional Medicine of National Institute for Pharmaceutical Research and Development, (NIPRD), Abuja, Nigeria where a voucher specimen (NIPRD /H/6228) was deposited at the herbarium for reference.
2.1.Chemicals and reagents
All chemicals were purchased from Sigma -Aldrich, USA
2.2Extraction of plant material
The air-dried and powdered plant material (200g) was extracted with 5 L methanol for 48 h using a Soxhlet apparatus (Quicket, UK). The extract was filtered through Whatmann No. 1 (Whatmann International Ltd, Maidstone, UK) paper and evaporated under reduced pressure using a rotary evaporator to a yield of 20.17 %w/w referred as crude extract. The dried extract was stored at 4 o C until used.
2.3.Fractionation and isolation
The fractionation was done as previously described by Builders et al [11] . MF4 was further refractionated using a C-18 silica gel as stationary phase with solvent system Methanol: Water (4:1) of constituent to obtain crude extract of phenol (4.15%w/w).
2.4.Detection of chemical constituents of phenol extract
The phenol extract was subjected to qualitative chemical screening for the identification of various classes of chemical constituents using methods described by (5).
2.5.Thin layer chromatography
Identification of tannins and flavonoids was further carried out by TLC using pre-coated silica gel 60GF 254 Merck plates with different eluting systems (6).
2.6.Infra-red(IR) spectroscopy
The IR spectrum was recorded on a Shimadzu FTIR-84000S spectrophotometer.
2.7.Identification of functional groups
Functional groups were detected by method of Shriner et al (7).
2.8.Antioxidant potential
Ascorbic acid was used as the antioxidant standard and the methanol soluble portion of the phenol compound was extracted and concentrated and used for the antioxidant assessment.
The phenol compound and ascorbic acid at equal concentrations of 0.0313, 0.0625, 0.1250, 0.25, 0.5, and 1 mg/ml in methanol were prepared. The radical scavenging activities of the extract against 2, 2-Diphenyl-1-picryl hydrazyl radical (DPPH) were determined by UV spectrophotometric methods [8] . I ml quantities of the extract and ascorbic acid were placed in a test tube, and 3 ml of methanol added followed by 0.5 ml of 1mM DPPH in methanol. These were allowed to stand for 30 min before the absorbance were taken at 517 nm. The blank solution consists of the same amount of methanol and DPPH. The radical scavenging activity presented as percentage inhibition was calculated using equation 1.
Where: Ab is the absorbance of the blank sample and Aa is the absorbance of the drug (phenol compound or ascorbic acid).
2.9.Animals
As experimental hosts, 6-week-old out bred male (20 ± 2 g) and female (22 ± 2 g) Swiss albino mice obtained from the animal facility centre of the Department of Pharmacology and Toxicology, National Institute for Pharmaceutical Research and Development (NIPRD), Abuja, Nigeria was used for the study. The animals were housed in standard cages, with standard feed and water given ad libitum, and they were acclimatized for 14 days prior to the experiments. All animal experiments were performed according to Good Laboratory Practice (GLP) regulations [9] . The principle of laboratory animal care [10] was also followed in this study. The LD50 of the compound was determined using male Swiss albino mice by oral route using the method of Lorke et al [11] .
2.9.1.Parasite inoculation
The malaria parasite used was a chloroquine-sensitive strain of Plasmodium berghei berghei (NK-65), obtained from the National Institute for Medical Research (NIMR), Lagos, Nigeria and kept at the Department of Pharmacology and Toxicology, NIPRD, Idu, Abuja, Nigeria. The parasites were maintained by serial blood passage in mice. Parasitized erythrocytes were obtained from a donor-infected mouse by cardiac puncture in heparin and made up to 20 ml with normal saline. Animals were inoculated intraperitoneally with infected blood suspension (0.2 ml) containing 1x 10 7 parasitized erythrocytes on day zero. Infected mice with parasitaemia of 5-7% were allocated to five groups of six mice each (12).
2.9.2.In vivo antimalarial assay
A series of experiments were carried out to evaluate the in vivo anti-malarial activities of the phenol compound of African locust bean tree stem bark at 5, 10, and 25 mg/kg doses as compared to control groups treated with 0.2 ml of normal saline and reference groups treated with standard drugs (Chloroquine diphosphate 25 mg/kg/day ). Malaria infection was first established in male mice by the intraperitoneal (i.p.) administration of donor male Swiss albino mouse blood containing about 1 × 10 7 parasites. The three different methods of treating malaria infections, i.e., 4-Day suppressive test, curative and prophylactic methods were applied according to Peters and Robinson [13] , Saidu et al [14] and Peters [15] respectively. The laboratory tests were started with oral administrations of the compound in the 4-day suppressive tests (early malaria infection) and further screened for their curative (established malaria infection) and prophylactic (residual malaria infection) activities. Thick blood smears were prepared and blood films were fixed with methanol. The blood films were stained with Giemsa, and then microscopically examined with 100-x magnification. The percentage suppression of parasitaemia was calculated for each dose level by comparing the parasitaemia in infected controls with those of treated mice [16] .
2.9.3.In vitro antimalarial assay 2.9.3.1.Patients" selection Three fresh blood specimens were collected from three patients suffering from fever and other malaria symptoms with confirmed infection by P. falciparum. Already prepared dried -in-acridine orange -stained thin smears were examined for Plasmodium species identification .The parasite density was determined by counting the number of infected erythrocytes among 20,000 erythrocytes from each patient, 4ml of venous blood was collected in a tube coated with EDTA. Samples with monoinfection due to Plasmodium falciparum and a parasite density between 1 and 2% were used for the in vitro antimalarial tests [17] .
2.9.3.2.In vitro test
The assay was performed in duplicate in a 96-wellmicrotiter plate, according to WHO method in vitro micro test (Mark III) [16] . RPMI 1640 (Sigma Company, USA) was the culture medium used for cultivation of P. falciparum [17] . Dilutions were prepared from the phenol compound and the final concentrations prepared by dilution were (5, 1, 0.5, 0.2, 0.1 and 0.05 µg/ml). Negative controls were treated with solvent and positive controls (Chloroquine phosphate) were added to each set of experiments. Fifty microliters from blood mixture media was added to each well in plate and incubated in a candle jar (with gas environment of about 3% O2, 6% CO2and 91% N2) [18] at 37.0 0 C for 24-30 h. After incubation, contents of the wells were harvested and stained for 5 min in an already prepared dried -in-acridine orange reagent. The parasites were counted in five fields of vision (> 200 total cells) using a fluorescence microscope (Partec cyscope fluorescence microscope, Germany) at a magnification of 40.
2.9.3.3.Data analysis
Data were expressed as the mean ± standard error of mean (SEM). The Student"s t-test and ANOVA (one-or two-way) were used to test the differences between groups. Differences between means at 5% level (P ≤ 0.05) were considered significant. The IC 50 values were determined graphically on a log doseresponse curve (log concentration versus percent inhibition curves) by interpolation while those values for the antioxidant activities were calculated from the linear regression of plots of concentration of the test compounds (mg/ml) against the percentage of inhibition of 2, 2-Diphenyl-1-picryl hydrazyl.
III.

Results
3.1.Phytochemical test
Phytochemical screening of the phenol extract of P.biglobosa revealed the presence of tannins and phenols. Alkaloids, carbohydrate, saponins, flavonoids, terpenes, glycosides and sterols were not detected (Table 1) . 
3.2.Thin layer chromatography
The presence of tannins and phenols was confirmed by thin layer chromatography. Six compounds were separated with R f values ranging from 0.88 to 0.97, two of the compounds had similar R f values with the standards. Formation of brown spots with I 2 vapour indicated the presence of organic compounds and the appearance of bluish green spots with ferric chloride showed the presence of phenolic compounds (Table 2) . 
3.3.IR spectroscopy
In the IR spectrum analysis the phenol extract showed strong absorption between 3200 and 3600cm -1 , indicating carboxylic hydroxyl function. Absorption between 2500 and 3000 cm -1 were considered as hydroxyl function. Maximum absorption peaks of CH function appeared at 2900 cm 
3.4.Functional group tests
Results of functional group tests indicated the presence of phenolic rings, double bonds and aldehyde/ketone groups (Table 4) . 
3.5.Acute toxicity test
Doses above 500 mg/kg were safe and devoid of any adverse clinical symptoms, The LD 50 was calculated to be >500 mg/kg P.O.
3.6.In vivo antiplasmodial activity of phenol extract
The photomicrograph of the in vivo antiplasmodial activity of the phenol extract is presented in (Figure 2 ). Phenol extract dose-dependently reduced the mean parasitic count in suppressive, curative and prophylactic antiplasmodial study. Chloroquine also exhibited a similar antiplasmodial activity (Figure 3 ).
In vitro antiplasmodial activity of the phenol extract
The photomicrograph of the in vitro antiplasmodial activity of the phenol extract is presented in (Figure 4 ). A. Complete RPMI medium B. Untreated RPMI medium with P.falciparum C. RPMI medium treated with phenol extract
The compound showed a significant concentration dependent growth inhibition of P. falciparum, the IC 50 of the phenol extract of P. biglobosa was determined as 0.51µg/ml. Maximum plasmodia inhibition of 79.2 ±1.2 % for the phenol extract and 98.8±1.4% for artemisinin at a concentration of 1 µg/ml (figure 5).
3.7.Antioxidant activity
The antioxidant activities of phenol extract and ascorbic acid increased with increase in concentration. The phenol extract and ascorbic acid showed maximum DPPH radical scavenging activity of 97.03 and 97.43%. Phenol extract exhibited strong free radical scavenging activity at all concentrations from (0.0313-1mg/ml) with inhibition of (90.44 -97.43%), similar inhibition was observed with ascorbic acid (Fig.6 ).
IV.
Discussion
Phytochemicals are non-nutritive plant chemicals that have protective (or) diseases preventive properties. Plant produces these chemicals to protect itself but recent research demonstrates that many phytochemicals can protect humans against diseases (19) . The phytochemical analysis of phenol extract of P.biglobosa showed the presence of phenols and tannins, studies indicated the presence of phenols and tannins in P.biglobosa [12, 20] .Thin layer chromatography studies showed the confirmation of phenolic compounds like tannins and phenols R f 0.78 and 0.97 values which were more close to the standards R f 0.78 and 0.97 values with prominent bluish green coloration. Prominent O-H stretching confirms the presence of phenolic compound in P.biglobosa, the phenolic compounds have rings of phenols, double bond conjugation system and aldehyde or ketone groups.
There was no mortality in animals at all doses of the compound up to 500 mg /ml. The absence of death at doses up to 500 mg extract /kg showed that LD50 of the NBA is greater than 500mg/kg P.O. Toxicological studies on the crude extract had already been conducted by Builders et al [21] , this will go a long way to specify the parameters necessary to the development of a drug.
The phenol extract elicited potent activity against the rodent malaria parasite used in this study, the extract also exhibited very good antiplasmodial activity against the clinical isolate of P.falciparum. The results of this study suggest that the phenol extract has potential value in the treatment of malaria. Many secondary metabolites of plants" origin have been shown to have antiplasmodial activity [22] , The antiplasmodial activities of many phenolic compounds had been described by Laphookhieo et al [23] and Kusch et al [24] .
African locust bean tree is used prominently as food and medicine by many traditional medicine practitioners in Nigeria e.g. The stem bark and leaf of African locust bean tree are used traditionally for the treatment of malaria [4, 25] . In vivo and in vitro antiplasmodial activities of leaves of P.biglobosa had already been evaluated by Builders et al [12] , studies on the efficacy of the stem bark of this important medicinal plant had already been reported by Builders et al [20] , and also anti-inflammatory and analgesic activities of this plant had been reported by Kouadio et al [26] .
Studies carried out by Milligo-Kone et al [27] indicated that the stem bark of P.biglobosa possessed antioxidant activities which might be attributed to the phenolic composition of the plant. Regarding the mechanism of action of phenol extract, our attention was focused on antioxidant activity. The presence of phenolic compounds in the plant is likely to be responsible for the free radical scavenging effects observed. Phenolic compounds are tannins and plant phenolics are a major group of compounds that act as primary antioxidants or free radicals scavengers [28] . The antioxidant activity of phenolic compounds is mainly due to their redox properties, which can play an important role in adsorbing and neutralising free radicals, quenching singlet and triplet oxygen, or decomposing peroxides [23] .
The antioxidant phenolic compounds have also been shown to exert antiplasmodial activity by elevating the red blood cell oxidation and inhibiting the parasite"s protein synthesis and also counteract the oxidative damage induced by the malaria parasite [5] . Thus, the antioxidant activities of this compound may represent another mechanism that contributes to its antiplasmodial activity.
V. Conclusion
Phenolic compounds were found to be the major antimalarial componens of P.biglobosa. Phenolic compounds account for most of the in vivo and in vitro antiplasmodial effect of this plant. Antioxidant activity may represent mechanism that contributes to its anti-malarial activity. This justifies the use of stem bark of P.biglobosa in Nigerian folk medicine for the treatment of malaria. Further investigation, including the identification of chemical structures of these compounds is likely to yield new anti-malarial drug candidates.
